Understanding the well-being of employed men with newly diagnosed solid tumors
The Intersection of Oncology Care and Worker Well-Being
This study looks at how low-income men with newly diagnosed solid tumors feel and cope with work challenges while they go through treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 21 Years to 70 Years |
| Sex | Male |
| Sponsor | University of Colorado, Denver Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT05250284 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the well-being experiences of low-income men diagnosed with primary solid tumors as they undergo treatment. It will assess their employment status and related challenges at three time points: baseline, start of treatment, and 12 months later. The study will utilize linear probability models and logistic models to estimate employment likelihood and hours worked, while well-being will be measured using the Worker Well-Being Questionnaire and PROMIS domains. The focus is particularly on how work status impacts overall well-being during the treatment continuum.
Who should consider this trial
Good fit: Ideal candidates are employed men aged 21 to 70 who have recently been diagnosed with a first primary solid tumor and are within two months of starting treatment.
Not a fit: Patients who are not employed or those who do not meet the age and diagnosis criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights that improve support systems for employed cancer patients, enhancing their well-being during treatment.
How similar studies have performed: While studies on cancer patient well-being exist, this specific focus on employed low-income men undergoing treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males * Ages 21 to 70 * Newly diagnosed with a first primary solid tumor * colorectal, lung, and head and neck * Currently employed (defined as working 10+ hours per week) with the intention to continue working or return to work * Within 2 months of initiating infusion chemotherapy, oral agent, or radiation therapy
Where this trial is running
Aurora, Colorado
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Cathy Bradley — University of Colorado, Denver
- Study coordinator: Carol Brown, PhD
- Email: carol.brown@cuanschutz.edu
- Phone: 562.587.9123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.